These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26423805)

  • 1. Effect of rituximab on adult Burkitt's lymphoma: a systematic review and meta-analysis.
    Nie M; Wang Y; Bi XW; Xia Y; Sun P; Liu PP; Li ZM; Jiang WQ
    Ann Hematol; 2016 Jan; 95(1):19-26. PubMed ID: 26423805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and prognostic analysis of 186 children with Burkitt's lymphoma].
    Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
    Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):605-610. PubMed ID: 30078243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
    Li YX; Yin QS; Ai H; Mi RH; Zhang LN; Li YF; Wei XD; Song YP
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):605-610. PubMed ID: 30818930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
    Wang YC; DU WC; Yin CY; Gong X; Li YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):561-565. PubMed ID: 35644197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
    Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
    AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience].
    Baryakh EA; Tyurina NG; Vorobyev VI; Gemdzhyan EG; Mangasarova YK; Klyasova GA; Kovrigina AM; Obukhova TN; Zvonkov EE; Vernyuk MA; Chervontseva AM; Polyakov YY; Misyurina АЕ; Valiev TT; Zherebtsova VA; Magomedova AU; Galstyan GM; Yatskov KV; Nesterova ES; Vorobyev AI; Kravchenko SK
    Ter Arkh; 2015; 87(7):4-14. PubMed ID: 26390720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
    J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.
    Stepniak A; Czuczwar P; Szkodziak P; Wozniakowska E; Wozniak S; Paszkowski T
    Arch Gynecol Obstet; 2017 Oct; 296(4):653-660. PubMed ID: 28770352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rituximab on primary central nervous system lymphoma: a meta-analysis.
    Song Y; Wen Y; Xue W; Zhang Y; Zhang M
    Int J Hematol; 2017 Nov; 106(5):612-621. PubMed ID: 28900847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
    Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
    J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
    Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
    Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
    Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008909. PubMed ID: 23832787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis.
    Ren YR; Jin YD; Zhang ZH; Li L; Wu P
    Chin Med J (Engl); 2015 Feb; 128(3):378-83. PubMed ID: 25635435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
    Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
    Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
    Yokohama A; Tsukamoto N; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Nojima Y
    Ann Hematol; 2004 Feb; 83(2):120-3. PubMed ID: 14513289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.
    Schulz H; Bohlius JF; Trelle S; Skoetz N; Reiser M; Kober T; Schwarzer G; Herold M; Dreyling M; Hallek M; Engert A
    J Natl Cancer Inst; 2007 May; 99(9):706-14. PubMed ID: 17470738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4.
    Zhen Z; Zhu J; Wang J; Lu S; Sun F; Huang J; Sun X
    Pediatr Hematol Oncol; 2020 Sep; 37(6):489-499. PubMed ID: 32364412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
    Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
    East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
    Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM
    Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.